
News|Articles|October 12, 2012
Resuming warfarin after GIB event decreases risk of thrombosis, death
Patients who experience a warfarin-associated gastrointestinal tract bleeding event should resume anticoagulation therapy during the 90 days following the event to decrease the risk of thrombosis and death, according to a study published online in the Archives of Internal Medicine.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Overlooked bladder nerves now thought to reduce UTI burden through pain signaling, study shows
2
Real-World Usage of Biologics in Psoriatic Arthritis
3
FDA approves $2.7 million gene therapy for rare metabolic disorder
4
Medicare beneficiaries are paying more for price-negotiated drugs, survey finds
5





















